Delivery Order SPE2DB20D1109-SPE2DB25FP57A
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,406.51 to AmerisourceBergen Drug Corp for Contrave ER 8-90 mg tablets (120 count) on August 1, 2025, with completion targeted for August 4, 2025. This competitively awarded, firm fixed-price delivery order utilizes no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,061.90 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Contrave ER 8-90 mg tablets (120-unit quantity). This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,515.09 delivery order for Contrave ER 8-90 mg tablets (120-count units) on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a $1,743.16 firm fixed price delivery order to AmerisourceBergen Drug Corp for Contrave ER 8-90 mg tablets (120 count) on September 10, 2025, with completion scheduled for September 11, 2025. This non-set-aside competitive award was fulfilled at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $4,829.52 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Contrave ER 8-90 mg tablets (120-count units). This contract represents a firm fixed-price delivery order with no set-aside designation, executed through competitive procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order carries an ultimate completion date...
- The Defense Logistics Agency awarded a delivery order valued at $1,352.44 to AmerisourceBergen Drug Corp for the supply of Contrave ER 8-90 mg tablets (120 count) on September 11, 2025, with completion expected by September 12, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $2,616.81 to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Contrave ER 8-90 mg tablets (120 count). This is a firm fixed-price delivery order with performance scheduled for completion by August 28, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The contract was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Contrave ER 8-90 mg tablets (120-count), with a contract ceiling value of $1,654.88. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,563.72 to AmerisourceBergen Drug Corp for the supply of Contrave ER 8-90 mg tablets (120 count), with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger indefinite...
- The Defense Logistics Agency awarded a $1,072.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 120 tablets of Contrave ER 8-90 mg on September 2, 2025, with completion scheduled for September 3, 2025. This non-set-aside award represents a single delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026. The...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP57ADelivery Order
The Defense Logistics Agency awarded a $4,065.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Contrave ER 8-90 mg tablets (120-count units) on August 13, 2025, with completion targeted for August 14, 2025. This non-set-aside award represents a standard pharmaceutical supply transaction under the company's broader federal contract portfolio. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor and critical vendor for federal medical procurement. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications and medical supplies to military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. The Contrave supply aligns with the company's extensive portfolio of pharmaceutical products delivered through competitively awarded contracts with the Defense Logistics Agency, supporting federal medical supply chain requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 8/13/25 |